comprehensive -WSS

comprehensive

author：leisure time 2025-09-29 22:53:28 - browse：31

WASHINGTON, DC - NOVEMBER 27: U.S. President Joe Biden speaks about supply chain resilience during an event in the Indian Treaty Room at the Eisenhower Executive Office Building on November 27, 2023 in Washington, DC. — President Biden spoke about supply chain resilience and drug shortages. Alex Wong/Getty Images

WASHINGTON — President Biden’s new plan to curb drug shortages by boosting domestic drug production won’t expand the supply of the chemotherapies that are currently in shortage, an administration official confirmed. The limited scope surprised experts, who told STAT Biden could have included those drugs in the effort.

The 15 cancer drugs in short supply account for only a little more than 10% of the drugs on FDA’s shortage list. But chemotherapies are far more crucial than many other drugs experiencing shortages, which include injections of amino acids and multivitamins, and sterile water. Gut-wrenching stories about cancer patients being switched to less-effective drugs have caused cancer doctors to agitate for government solutions.

Biden announced last week that he plans to use the Defense Production Act to get companies to make essential medicines and their ingredients in the United States. The administration will spend $35 million to boost domestic production of key starting materials for drugs that hospitals commonly use and are prone to shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Maui wildfire now ranks as the fifth

WSS

FDA panel signals lack of confidence in Amgen cancer drug data

Judge sides with young activists in first

VC firm General Catalyst wants to buy a health system

What to know about the judge who will handle the Trump case

Phenylephrine and the overlooked value of the placebo effect

BMS, looking to build heart drug business, turns to AI for diagnosis

knowledge

comprehensive

entertainment

Apple is now the first public company to be valued at $3 trillion

Liquid biopsy for lung cancer is launched by Delfi

Jerome Adams on the need for new antivirals for Covid

Bill would stop addiction treatment from triggering child abuse inquiry

Psychedelics group wrestles with new pharma identity

Indictment alleges Trump's ex

Cancer drug shortages should be causing more outrage

After Optum profits sink, UnitedHealth makes changes

Duchenne breakthrough therapy leaves behind pioneering families

VC firm General Catalyst wants to buy a health system

explore

When women are denied an abortion, their children fare worse than peers

FDA rejects Alnylam's heart disease treatment over insufficient data

Aspartame and sugar

A Q&A with the global head of Boehringer Ingelheim's innovation unit

VC firm General Catalyst wants to buy a health system

Mark Cuban is blaming the wrong people for high drug costs

hotspot

entertainment

hotspot

leisure time